News
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
3h
Barchart on MSNThis Blue-Chip Stock Is 20% Off Its Highs. Should You Buy the Dip?Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...
Research shows that COVID tends to spike twice annually — once in the winter and once in the summer, and, like past years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results